The Journal for Nurse Practitioners
Volume 4, Issue 5 , Pages 351-356 , May 2008

Prenatal Screening: New Guidelines, New Challenges

  • Rita W. Driggers
    • ,
  • Diane C. Seibert

      Affiliations

    • Rita W. Driggers, MD, is director of maternal/fetal medicine at the National Naval Medical Center in Bethesda, Maryland. Diane C. Seibert, PhD, CRNP, is associate professor and director of the family nurse practitioner program at the Graduate School of Nursing, Uniformed Services University of the Health Sciences in Bethesda, Maryland. The views expressed in this article are those of the authors and do not reflect the official policy or position of the Department of the Navy, the Uniformed Services University, the Department of Defense, or the US government. In conjunction with national ethical standards, the authors report no relationships with business or industry that represent a conflict of interest.

References 

  1. The American College of Obstetricians and Gynecologists Practice Bulletin #77. Screening for Fetal Chromosomal Abnormalities. January 2007.
  2. The American College of Obstetricians and Gynecologists Practice Bulletin #88. Invasive Prenatal Testing for Aneuploidy. December 2007.
  3. Brock DJ , Scrimgeour JB , Steven J , Barron L , Watt M . Maternal plasma alpha-fetoprotein screening for neural tube defects . Br J Obstet Gynaecol . 1978;85(8):575–581
  4. Merkatz IR , Nitowsky HM , Macri JN , Johnson WE . An association between low maternal serum alpha-fetoprotein and chromosome abnormalities . Am J Obstet Gynecol . 1984;148(7):886–894
  5. Bogart MH , Pandian MR , Jones OW . Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities . Prenat Diagn . 1987;7(9):623–630
  6. Wald NJ , Cuckle HS , Densem JW , et al.   Maternal serum unconjugated oestriol as an antenatal screeing for Down's syndrome . Br J Obstet Gynaecol . 1988;95(4):334–341
  7. Malone F , Carick JA , Ball RH , et al.   First-trimester screening, or both, for Down's syndrome. First and Second-Trimester Evaluation of Risk (FASTER). Research consortium . N Engl J Med . 2005;353:2001–2011
  8. Wald NJ , Kennard A , Hackshaw A , McGuire A . Antenatal screening for Down's syndrome . J Med Screen . 1997;4:181–246
  9. Vintzileos AM , Campbell WA , Rodis JF , et al.   The use of second-trimester genetic sonogram in guiding clinical management of patients at increased risk for fetal trisomy 21 . Obstet Gynecol . 1996;87:948–952
  10. Nicolaides KH , Azar G , Byrne D , et al.   Fetal nuchal translucency: ultrasound screening for chromosome abnormalities in the first trimester of pregnancy . BMJ . 1992;304:867–869
  11. Wald NJ , Kennard A , Hackshaw AK . First trimester serum screening for Down's syndrome . Prenat Diagn . 1995;15(13):1227–1240
  12. Wald NJ , Hackshaw AK . Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome . Prenat Diagn . 1997;17(9):821–829
  13. Souka AP , Von Kaisenberg CS , Hyett JA , et al.   Increased nuchal translucency with normal karyotype . AJOG . 2005;192:1005–1021
  14. Spencer K , Cowans NJ , Avgidou K , Nicolaides KH . First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death . Ultrasound Obstet Gynecol . 2006;28(5):637–643
  15. Spencer K , Cowans NJ , Avgidou K , et al.   First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of small for gestational age fetuses . Ultrasound Obstet Gynecol . 2008;31(1):15–19
  16. Spencer K , Cowans NJ , Molina F , et al.   First-trimester ultrasound and biochemical markers of aneuploidy and prediction of preterm or early preterm delviery . Ultrasound Obstet Gynecol . 2008;31(2):147–152
  17. Cuckle HS , Malone FD , Wright D , et al.   Contingent screening for Down syndrome-results from the FaSTER trial . Prenat Diagn . 2008;28(2):89–94
  18. Romero R , Jeanty P , Reece EA , et al.   Sonographically monitored amniocentesis to decrease intraoperative complications . Obstet Gynecol . 1985;65:426–430
  19. Leschot NJ , Verjaal M , Treffers PE . Risks of midtrimester amniocentesis; assessment in 3,000 pregnancies . Br J Obstet Gynaecol . 1985;92(8):804–807
  20. Multicentre randomized clinical trial of chorion villus sampling and amniocentesis. First report. Canadian Collaborative CVS-Amniocentesis Clinical Trial Group . Lancet . 1989;1:1–6
  21. Rhoads GG , Jackson LG , Schlesselman SE , et al.   The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities . N Engl J Med . 1989;320:609–617
  22. Caughey AB , Hopkins LM , Norton ME . Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss . Obstet Gynecol . 2006;108:612–616
  23. Mujezinovic F , Alfirevic Z . Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review . Obstet Gynecol . 2007;110:687–694
  24. Brambati B , Tului L . Prenatal genetic diagnosis through chorionic villus sampling . In:  Milunski A editors. Genetic disorders and the fetus: diagnosis, prevention, and treatment . 5th ed.. Baltimore: Johns Hopkins University Press; 2004;p. 179–213

PII: S1555-4155(08)00132-3

doi: 10.1016/j.nurpra.2008.03.003

The Journal for Nurse Practitioners
Volume 4, Issue 5 , Pages 351-356 , May 2008

Article Tools